title: Assessing drug safety in human tissues - what are the barriers?
authors.affiliation: National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London NW1 2BE, UK.
authors.forename: Anthony
authors.initials: A
authors.lastname: Holmes
authors.affiliation: Stem Cells for Safer Medicines (SC4SM), London SW1E 6QT, UK.
authors.forename: Frank
authors.initials: F
authors.lastname: Bonner
authors.affiliation: Medicines and Healthcare products Regulatory Agency (MHRA), London SW1W 9SZ, UK.
authors.forename: David
authors.initials: D
authors.lastname: Jones
mesh_terms: D000818:Animals; D003625:Data Collection; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control*; D006801:Humans; D023421:Models, Animal; D018570:Risk Assessment / Q000379:methods; D018675:Toxicity Tests / Q000379:methods*